Loading organizations...
The University of Texas System operates as a comprehensive public university system comprising fourteen academic and health institutions across the state. Its core mission is to advance society through higher education, pioneering research initiatives, and delivering essential healthcare services. The System's institutions offer a wide array of programs and conduct significant scientific and medical advancements.
Established over 140 years ago, The University of Texas System was created through legislative action to serve the evolving educational and healthcare needs of Texas citizens. This foundational insight centered on creating a unified, state-supported framework to cultivate intellectual capital and provide critical public services, thereby improving the quality of life for Texans.
The System's vast network serves a diverse student body and the broader community, both within Texas and globally, through its academic offerings and healthcare facilities. Its overarching vision is to foster discovery, cultivate future leaders, and drive innovation that yields a profound and lasting impact on human progress and societal well-being.
Key people at University of Texas System.
Key people at University of Texas System.
University of Texas System has 6 tracked investments across 6 companies. The latest tracked deal is $5.0M Series A in Cerebri AI Inc. in June 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2018 | Cerebri AI Inc. | $5.0M Series A | Elliott Robinson | Bessemer Venture Partners, Leawood Venture Capital, WorldQuant Ventures |
| Dec 1, 2017 | GenXComm | $7.0M Series A | Dan Artusi | Matrix, Walden International, Lip-Bu Tan, Azure Capital Partners, Bandgap Ventures, Capital Factory, FAM Capital Partners, Nick Tulloh, WS Investments |
| Jun 7, 2017 | Lung Therapeutics | $14.3M Series B | Aaron Fletcher | UT Horizon Fund |
| Aug 9, 2016 | Alafair Biosciences | $2.0M Series A | Kyle Cox | UT Horizon Fund |
| Mar 1, 2015 | Aeglea BioTherapeutics | $44.0M Series B | Armen Shanafelt, Novartis | Ally Bridge Group, Cowen Healthcare Investments, Jennison Associates, OrbiMed, Rajeev Shah, Rock Springs Capital, UT Horizon Fund, Venrock |
| Oct 24, 2011 | MyEdu | $10.0M Other Equity | University of Texas System | — |